Preβ1-high-density lipoprotein binds to TG-rich lipoproteins and its release is impaired in the postprandial state among patients with poorly controlled type 2 diabetes
BackgroundAlthough preβ1-high-density lipoprotein (preβ1-HDL) promotes cholesterol efflux, high fasting preβ1-high-density lipoprotein levels after breakfast are reduced in patients with poorly controlled type 2 diabetes.ObjectiveThis study investigated whether preβ1-high-density lipoprotein binds to triglyceride (TG)-rich lipoproteins (TGRLs) in the postprandial state and is released during lipolysis.MethodsWe measured preβ1-high-density lipoprotein concentrations, lecithin-cholesterol acyltransferase (LCAT) activity, and LCAT-dependent preβ1-high-density lipoprotein conversion before and after breakfast in patients with diabetes. We also performed <i>in vitro</i> studies using TGRLs. Preβ1-high-density lipoprotein was quantified by enzyme-linked immunosorbent assay and native two-dimensional gradient gel (N-2D-gel) electrophoresis.ResultsBefore breakfast, the diabetes group had higher preβ1-high-density lipoprotein concentrations than the healthy controls; after breakfast, levels in the two groups were similar. Neither LCAT mass nor the LCAT-dependent preβ1-high-density lipoprotein conversion rate changed after breakfast. Mixing of fasting plasma with chylomicrons or very-low-density lipoprotein (VLDL) reduced the preβ1-high-density lipoprotein level by 15% ± 4% and 45% ± 10%, respectively. N-2D-gel electrophoresis showed that preβ1-high-density lipoprotein was generated by bacteria-derived TG lipase only from postprandial VLDL of patients with type 2 diabetes.ConclusionPreβ1-high-density lipoprotein binds to TGRLs in the postprandial state and is released during lipolysis, implying that postprandial hyperlipidemia impairs reverse cholesterol transport in patients with poorly controlled type 2 diabetes.
Authors
- Yoshifumi Fukushima
- Yuri Ichikawa
- Takashi Miida (ORCID: https://orcid.org/0000-0002-4294-8030)
- Satoshi Soda (ORCID: https://orcid.org/0000-0001-5720-6876)
- Kazumasa Sekihara (ORCID: https://orcid.org/0009-0001-3795-4604)
- Yuna Horiuchi
- Utako Seino
- Atsushi Hori (ORCID: https://orcid.org/0009-0000-1961-7404)
- Satoshi Hirayama (ORCID: https://orcid.org/0000-0003-3303-404X)
- Tsuyoshi Ueno
- Katsuo Kubono
Institutions
- University of Miyazaki (JP)
- Tokyo Gakugei University (JP)
- Juntendo University (JP)
- Niigata City General Hospital (JP)
- Juntendo University Hospital (JP)
Publication Details
- Journal
- Annals of Clinical Biochemistry International Journal of Laboratory Medicine
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1177/00045632251328154
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00